NCT04061135

Brief Summary

The purpose of this study is to investigate the brain activity associated with motor and non-motor symptoms of movement disorders, including Parkinson's disease (PD) and essential tremor. These movement disorders commonly have significant non-motor features, such as depression, cognitive and memory impairment, decreased attention, speech and language disturbances, and slower processing speeds. The investigators are interested in the brain activity associated with these motor and non-motor symptoms, and propose to investigate changes in brain activity while the investigators perform recordings of the surface and deep structures of the brain, in addition to the typical recordings the investigators perform, during routine deep brain stimulation (DBS) surgery.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
35mo left

Started Sep 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress70%
Sep 2019Mar 2029

First Submitted

Initial submission to the registry

July 16, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 19, 2019

Completed
13 days until next milestone

Study Start

First participant enrolled

September 1, 2019

Completed
8.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2028

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2029

Last Updated

March 17, 2026

Status Verified

March 1, 2026

Enrollment Period

8.6 years

First QC Date

July 16, 2019

Last Update Submit

March 14, 2026

Conditions

Keywords

Parkinson's disease

Outcome Measures

Primary Outcomes (6)

  • Accuracy via Simon Task (% correct)

    In the Simon task, participants are instructed to respond with a right or left button press (Right = Red, Left = Blue) according to how a word is printed on a screen ("RED" or "BLUE"), regardless of the color in which the word is printed. This is a measurement of accuracy (% correct, ranging from 0-100, with higher scores indicating better performance)

    Baseline

  • Response times via Simon Task (sec)

    In the Simon task, participants are instructed to respond with a right or left button press according to the word "RIGHT" or "LEFT" that appears on a screen, regardless of where on the screen it actually appears. This is a measurement response times (continuous measure, from 0-4000 milliseconds) between correct and incorrect responses.

    Baseline

  • Simon Effect on Response times (sec)

    Participants will perform the Simon task as described, and the Simon effect will be calculated as the difference in response times between congruent and incongruent trials

    Baseline

  • Simon Effect on Accuracy (% correct)

    Participants will perform the Simon task as described, and the Simon effect will be calculated as the difference in accuracy between congruent and incongruent trials

    Baseline

  • UPDRS 3 motor score (0-108)

    Participants will undergo motor evaluation using the validated United Parkinson's disease Rating Scale (UPDRS) part 3

    Baseline

  • Dementia Rating Scale Score (0-144 points)

    Participants will undergo neuropsychological testing as part of routine care, including the Dementia Rating Scale

    Baseline

Study Arms (2)

Treatment

EXPERIMENTAL

Parkinson's Disease Patients receiving DBS electrodes

Procedure: Response Inhibition and Deep Brain Stimulation in Parkinson's disease

Control

NO INTERVENTION

Control subjects will be non-Parkinson's Disease patients with essential tremor

Interventions

After creation of the burr hole and prior to DBS electrode placement, 1-2 subdural strip electrodes will be placed anteriorly or posteriorly from the cranial opening. These electrodes are routinely placed using this technique for seizure mapping, with arrays of electrodes (up to 6) being placed around the perimeter of the opening.14 Subdural strips vary in length and contact size (e.g., the 6-contact Ad-Tech strip), and are currently placed predominantly for studies of sensorimotor function,13 including at our institution (IRB-140327003). Placement over prefrontal areas is performed at other institutions.11-13 The DBS surgery will then proceed according to routine practice, and following lead placement in the optimal desired location, the research task paradigm will begin.

Treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Eligible for DBS surgery based on multi-disciplinary consensus review
  • Have a diagnosis of Parkinson's disease or Essential Tremor
  • A minimum of 18 years of age
  • Willingness to participate in the paradigms described in the protocol

You may not qualify if:

  • Inability to provide full and informed consent
  • Are not surgical candidates due to co-morbid conditions or pregnancy
  • Have not undergone an adequate trial of conservative medical management
  • Have a clinical presentation for which DBS surgery is not indicated
  • Are not able to participate in study-related activities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alabama at Birmingham

Birmingham, Alabama, 35233, United States

RECRUITING

MeSH Terms

Conditions

Movement DisordersParkinson Disease

Interventions

Deep Brain Stimulation

Condition Hierarchy (Ancestors)

Central Nervous System DiseasesNervous System DiseasesParkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesSynucleinopathiesNeurodegenerative Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsSurgical Procedures, Operative

Study Officials

  • Nicole Bentley, MD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nicole Bentley, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

July 16, 2019

First Posted

August 19, 2019

Study Start

September 1, 2019

Primary Completion (Estimated)

March 31, 2028

Study Completion (Estimated)

March 31, 2029

Last Updated

March 17, 2026

Record last verified: 2026-03

Locations